Form 4: Scholar Rock COO & CFO Edward Myles Executes Stock Option and Sells Shares Under 10b5-1 Plan

Edward Myles, COO & CFO of Scholar Rock Holding Corp, exercised stock options and sold shares of common stock on October 7, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 7, 2024, Edward H. Myles, the COO & CFO of Scholar Rock Holding Corp, executed a stock option and sold shares of the company's common stock.
• The transactions were carried out under a Rule 10b5-1 trading plan adopted on March 7, 2024.
• Myles exercised an option to purchase 165,810 shares at a price of $13.83 per share.
• He then sold a total of 206,240 shares at varying weighted average prices: 111,972 shares at $25.61, 37,206 shares at $26.83, 25,812 shares at $27.27, and 31,250 shares at $29.05.
• Following these transactions, Myles directly owns 161,088 shares of Scholar Rock Holding Corp.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock transactions under a pre-arranged plan. There's no indication of positive or negative implications for the company's performance.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, although the existence of a 10b5-1 plan mitigates this concern.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• Rule 10b5-1 trading plans are widely used by corporate insiders to manage their stock sales in a compliant manner.
• Comparable companies such as BioMarin Pharmaceutical Inc. and Vertex Pharmaceuticals Incorporated also have executives who utilize 10b5-1 trading plans.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders, but the existence of a 10b5-1 plan suggests the transactions were planned and not based on inside information.

Key Dates